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ABSTRACT
Background and Objectives: We describe our experience with combined open and endovascular repair in patients who 
have aortic arch pathology. Subjects and Methods: This study is a retrospective analysis of 7 patients who underwent com-
bined open and endovascular repair for aortic arch pathology. Medical records and radiographic information were reviewed. 
Results: A total of 7 consecutive patients (5 men, 71.4%) underwent thoracic stent graft implantation. The mean age was 
59.9±16.7 years. The indication for endovascular repair was aneurysmal degeneration in 5 patients, and rupture or impend-
ing rupture in 2 patients. In all 7 cases, supra-aortic transposition of the great vessels was performed successfully. Stent graft im-
plantation was achieved in all cases. Surgical exposure of the access vessel was necessary in 2 patients. A total of 9 stent grafts 
were implanted (3 stent grafts in one patient). The Seal thoracic and the Valiant endovascular stent graft were implanted in 6 
patients and 1 patient, respectively. There were no post-procedure deaths or neurologic complications. In 2 patients, bleeding 
and injury of access vessel were noted after the procedure. Postoperative endoleak was noted in 1 patient. One patient died 
at 10 months after the procedure due to a newly developed ascending aortic dissection. No patients required secondary inter-
vention during the follow-up period. The aortic diameter decreased in 4 patients. In 3 patients, including 1 patient with endole-
ak, there was no change in aortic diameter. Conclusion: Our experience suggests that combined open and endovascular re-
pair for aortic arch pathology is safe and effective, with few complications. (Korean Circ J 2010;40:399-404)
KEY WORDS: Prostheses and implants; Aortic disease; Aortic aneurysm.
Received: March 17, 2010
Accepted: April 1, 2010
Correspondence: Eak Kyun Shin, MD, Department of Cardiology, Gil 
Medical Center, Gachon University of Medicine and Science, 1198 Gu-
wol-dong, Namdong-gu, Incheon 405-760, Korea
Tel: 82-32-460-3054, Fax: 82-32-469-1906
E-mail: ekshin@gilhospital.com 
cc This is an Open Access article distributed under the terms of the Cre-
ative Commons Attribution Non-Commercial License (http://creativecom-
mons.org/licenses/by-nc/3.0) which permits unrestricted non-commer-
cial use, distribution, and reproduction in any medium, provided the ori-
ginal work is properly cited.
Introduction
Aortic arch aneurysm or dissection repair, requiring car-
diopulmonary bypass and hypothermic circulatory arrest, re-
mains a surgical challenge with a high rate of mortality (7-
17%) and neurologic complication (4-12%).
1-3) Endovascular 
repair for thoracic and abdominal aortic aneurysm is associ-
ated with lower perioperative morbidity and mortality rates 
than conventional open repair, with similar early and midterm 
follow-up results.
4-8) Recently, combined open and endovas-
cular repair has emerged as an effective adjunct in the treat-
ment of various pathologies of the aortic arch, especially in 
the high-risk patient not suitable for conventional open repair 
owing to cardiovascular or pulmonary comorbidities.
9-13) In 
the current report, we describe our experience with combined 
open and endovascular repair in patients who had an aneury-
sm or dissection involving the aortic arch. 
Subjects and Methods
Patient population
From December 2007 to October 2009, 16 patients were 
treated at our institution with endovascular repair for thorac-
ic aortic disease. This study is a retrospective analysis of the 7 
patients who underwent combined open and endovascular 
repair for aortic disease involving the aortic arch with/without 
proximal descending aorta. Patient selection for combined 
repair was based on the length of the proximal landing zone 
and comorbidities. Patient demographics and clinical risk fac-
tors are shown in Table 1. Diagnosis was confirmed by enhanced 400   Combined Open and Endovascular Repair in Aortic Arch Disease 
computed tomography scan angiography (CTA) and angiog-
raphy in all cases. Patients in whom the distal extent of disease 
was confined to the thoracic aorta were included in this study. 
Cases of aortic trauma resulting in pseudoaneurysm or dis-
section were also included in the patient cohort. Our indica-
tions for endovascular repair were the following: 1) maximum 
aortic diameter ≥55 mm; 2) rapid aortic enlargement (≥10 
mm per year); 3) clinical or radiographic evidence of rupture 
or impending rupture; 4) intractable chest pain, despite maxi-
mal medical therapy.
Medical records and radiographic information were review-
ed to determine the operative indications, the repair technique, 
the peri-procedural complications and the outcomes. Tech-
nical success was defined as a successful stent graft deploy-
ment without death, conversion to open repair or diagnosis 
of endoleak before discharge. For each patient, the immedi-
ate post-procedural CTA was compared with the most recent 
CTA. The following parameters were recorded: presence of 
an endoleak and its nature, and overall maximal aortic diam-
eter. Adverse clinical events (mortality, respiratory failure, 
malperfusion, bleeding, vascular injury, renal failure, stroke 
and paraplegia) occurring during the peri or post-procedur-
al period and during follow-up were recorded.
Preoperative evaluation for proximal landing zone
For arterial access, preoperative evaluation was done by 
CTA scans to exclude major occlusive disease of the aortoili-
ac axis. These CT scans were also used as a tool to predict the 
required length of the intended proximal landing zone. As a 
prerequisite for successful stent graft placement, a proximal 
landing zone of at least 1.5 cm along the lesser curvature of the 
aortic arch was claimed. Furthermore, after supra-aortic trans-
position, an additional CTA scan was performed to reconfirm 
the effective length of the intended landing zone extension. 
Supra-aortic transposition
In all 7 cases, supra-aortic transposition of the great vessels 
was performed several days prior to endovascular stent grafting. 
Left subclavian-to-left carotid artery transposition
A standard approach through a skin incision parallel to the 
left clavicle was chosen. The left subclavian artery (LSCA) 
was divided at its origin at the level of the aortic arch. The ves-
sel was guided dorsal to the left jugular vein, and an end-to-
side anastomosis between the LSCA and the left common ca-
rotid artery (LCCA) was performed.
Double or triple-vessel transposition
Through an upper hemisternotomy approach, all supra-aor-
tic vessels were exposed. Prosthetic graft was used to connect 
the aorta to the brachiocephalic artery (BA), the LCCA and 
the LSCA because extensive mobilization of the supra-aortic 
vessels is not sufficient to accomplish tension free vascular 
transposition. 
Stent graft placement
All procedures were performed in an angiography suite, 
under general or local anesthesia. The right or left common 
femoral artery (CFA) was used for access in all the cases to 
place the endovascular stent grafts. In the majority of patients, 
stent graft was deployed using a percutaneous approach. 
Post-procedure, a suture-mediated closure device (Perclose
TM, 
Abbott Laboratories, Illinois, IL, USA) was used for closure of 
the access site (Preclose technique).
14) Surgical exposure of the 
access vessel was required in 2 patients who had a severely tor-
tuous CFA. Drainage of cerebrospinal fluid was performed 
in patients who required extensive aortic coverage or had had 
previous aortic surgery. Stent graft deployment was routinely 
performed under hypotonic conditions (60 mmHg systolic 
pressure) by overpacing at 180 beats per minute. Stent grafts 
from the same manufacturer were used when a patient requir-
ed multiple stent grafts. To achieve a satisfactory seal, devices 
were oversized in diameter by 15-20% in relation to the diam-
eter of the proximal landing zone. If an endoleak occurred af-
ter stent graft implantation, ballooning was carried out to make 
the stent graft closely adhere to the blood vessel wall. If the 
endoleak was caused by stent displacement or angulation, an 
aortic extending stent graft was implanted. 
Definition of endoleak
Type I endoleaks were defined as attachment site leaks, 
type Ia at the proximal attachment site and type Ib at the dis-
tal attachment site. Type II endoleaks were defined as branch 
leaks without attachment site connection. Type III endoleaks 
were defined as junctional leaks between stent grafts. 
Table 1. Demographics and clinical risk factors of patients (n=7)
n (%)
Sex
Male 5 (71.4)
Female 2 (28.6)
Age (years) 59.9±16.7
Hypertension 4 (57.1)
Diabetes mellitus 2 (28.6)
Coronary artery disease 2 (28.6)
Chronic obstructive pulmonary disease 0
Chronic renal insufficiency 1 (14.3)
Peripheral vascular disease 0
Prior open aortic surgery 1 (14.3)
Mean time from symptom onset to endovascular
  repair (days)
178.4±163.3
Mean time from supra-aortic transposition 
  to endovascular repair (days)
41.6±38.9Woong Chol Kang, et al.   401
Follow-up period
Patients were followed up according to a follow-up proto-
col that required a CTA scan and clinical evaluation. Addi-
tional investigations were obtained whenever indicated. 
Results
A total of 7 consecutive patients (5 men, 71.4%) were im-
planted with a thoracic stent graft for the treatment of aortic 
disease involving the aortic arch. The mean age at interven-
tion was 59.9±16.7 years (range, 28-76) and the mean time be-
tween the supra-aortic transposition and endovascular re-
pair was 41.6±38.9 days (range, 6-119). The mean time between 
symptom onset and endovascular repair was 178.4±163.3 
days (range, 48-430) (Table 1). Indications for endovascular 
repair were: aneurysmal degeneration in 5 cases (71.4%), rup-
ture or impending rupture in 2 cases (28.6%). 
Supra-aortic transposition
In all 7 cases, supra-aortic transposition of the great ves-
sels was performed prior to endovascular stent grafting. In 3 
patients who had an aneurysm extending from the ascending 
aorta, Y-shaped bypass surgery with a prosthetic graft to con-
nect the aorta to the BA, LCCA and LSCA was performed. 
In one patient, Y-shaped bypass surgery with a prosthetic graft 
connecting the aorta to the BA and LCCA was performed 
and followed by end-to-side anastomosis between the LCCA 
and LSCA (Fig. 1). In another patient who had two localized 
traumatic aortic dissections of the ascending aorta and the 
just distal LSCA, graft replacement was performed in the as-
cending aorta, followed by graft interposition between the 
aorta and the LCCA, and end-to-side anatomosis between 
the LCCA and the LSCA. In the remaining 2 cases, who had 
relatively limited aneurysms in the aortic arch, transposition 
of the LSCA onto the LCCA was performed (Table 2).
Procedural details of endovascular repair
Stent graft implantation was achieved in all cases. As de-
scribed above, surgical exposure of the access vessel was nec-
essary in 2 patients. Two different stent graft systems were 
used. The Seal thoracic endovascular stent graft (S & G bio-
tech, Seoul, Korea) was used in 6 patients and the 3 Valiant en-
dovascular stent grafts (Medtronic Inc, Santa Rosa, CA, USA) 
were implanted in 1 patient who had a long aortic aneurysm 
(Table 3). 
Postoperative results
There were no post-procedure deaths or neurologic com-
plications. In one patient who underwent the procedure via per-
cutaneous approach, continuous bleeding at the access site 
was noticed even though a suture-mediated closure device was 
used. Right CFA injury was noted and surgical repair per-
A  
D  
B  
E  
C  
F  
Fig. 1. Reconstructive three-dimensional computed tomography showed extensive aortic aneurysm involving the aortic arch and proximal 
descending thoracic aorta (A and B). Y-shaped bypass surgery with a prosthetic graft, to connect the aorta to the BA and the LCCA, was per-
formed (white arrow) and followed by end-to-side anastomosis of the LCCA and LSCA (open arrow) (C and D). After supra-aortic transposi-
tion of the great vessels, 3 Valiant stent grafts were implanted from the ascending aorta to the descending thoracic aorta in a telescopic fash-
ion to exclude extensive aortic aneurysm (E and F). BA: brachiocephalic artery, LCCA: left common carotid artery, LSCA: left subclavian artery.402   Combined Open and Endovascular Repair in Aortic Arch Disease 
formed. In another patient, a huge hematoma was noted in 
the groin area after the procedure. CTA showed active bleed-
ing from the right deep circumflex iliac artery, which was ma-
naged with coil embolization. There were no other postop-
erative complications. Postoperative endoleak was noted in 
1 patient on the follow up CTA. Therefore, the procedure was 
considered technically successful in 6 cases (85.7%) (Table 4). 
Late survival and secondary intervention
Clinical follow-up was available for all patients and the mean 
clinical follow-up period was 14.0±4.5 months (range, 4 to 
23 months). One patient died at 10 months after the proce-
dure due to a newly developed ascending aortic dissection. 
The patient had initially undergone stent graft deployment 
for type B aortic dissection. But type Ia endoleak was noted 
after the procedure. The follow-up CTA scan showed persis-
tent endoleak and slightly progressed aortic dissection. Con-
sequently, implantation of an additional stent graft was plan-
ned. After the LSCA-to-LCCA bypass surgery, the stent graft 
was deployed just proximal to the previous stent graft. Post-
procedure, the type Ia endoleak disappeared and follow-up 
CTA showed decreased aortic diameter with complete throm-
bosis of the false lumen. At 10 months after the procedure, the 
patient came to the emergency room with sudden onset chest 
pain and loss of consciousness. The CTA scan showed newly 
developed aortic dissection of the ascending aorta and hemo-
pericardium and the patient eventually expired. No patients 
required secondary intervention during the follow-up period.
Endoleak and aortic diameter
Follow up CTA scan showed persistent endoleak without 
change of aortic diameter in the patient who had showed en-
doleak immediately post-procedure. The aortic diameter de-
creased in 4 patients. In 3 patients including 1 patient who had 
endoleak, there was no interval change of aortic diameter. 
Discussion
Conventional surgical repair for aortic arch pathology car-
ries a high mortality and morbidity, with a particularly signifi-
cant incidence of neurologic injury.
1-3) Recent advances in st-
ent graft technology have enhanced the management of dise-
ases of the descending thoracic aorta by avoiding thoracotomy 
and expanded the group of patients eligible for treatment. Be-
cause of the complex anatomy of the aortic arch, however, 
repair of aortic arch pathology remains a significant endovas-
cular challenge as it requires preservation of the supra-aortic 
great vessels during the procedure. Moreover, insufficient pro-
ximal landing zone for stent graft deployment is a major lim-
itation of endovascular repair in most cases. Generally, a land-
ing zone length of more than 1.5 cm is considered acceptable, 
Table 2. Category and extent of supra-aortic vessel transposition
N
Success rate of supra-aortic vessel transposition (%) 7 (100)
Type of supra-aortic vessel transposition
Y-shaped bypass surgery with a prosthetic graft to connect the aorta to the BA, the LCCA, the LSCA 3
Y-shaped bypass surgery with a prosthetic graft to connect the aorta to the BA, the LCCA and anastomosis between  
  the LCCA and the LSCA
1
Graft replacement for ascending aorta followed by graft interposition between aorta and the LCCA, anastomosis between  
  the LCCA and the LSCA
1
Anastomosis between the LCCA and the LSCA 2
BA: brachiocephalic artery, LCCA: left common carotid artery, LSCA: left subclavian artery 
Table 3. Endovascular repair (n=7)
Indication for procedure (%) 
Increased aneurysm 5 (71.4)
Rupture or impending rupture 2 (28.6)
Approach (%)
Percutaneous 5 (71.4)
Surgical exposure of access vessel 2 (28.6)
Type of stent graft (%)
Seal thoracic 6 (85.7)
Valiant 1 (14.3)
Table 4. Results of procedure (n=7)
In-hospital outcomes (%)
Primary success 6 (85.7)
Endoleak 1 (14.3)
Bleeding 1 (14.3)
Vascular injury 1 (14.3)
Neurologic deficit 0
Malperfusion 0
Renal failure 0
Paraplegia 0
Respiratory failure 0
Death 0
Follow up outcomes (%)
Reintervention 0
Death 1 (14.3)Woong Chol Kang, et al.   403
although conflicting evidence exists in this regard.
15-18) 
On the other hand, a sufficient proximal landing zone can 
be achieved by transposition of the supra-aortic vessels. Im-
portantly, this procedure, which avoids the need for cardiopul-
monary bypass and aortic cross-clamping, may have advan-
tages for high-risk patients.
19) In addition, second-stage en-
dovascular repair may be performed much sooner than a se-
cond open procedure for patients requiring a two-stage ap-
proach. Bergeron et al.
20) reported results of combined open 
and endovascular repair for 15 aortic arch pathologies. The 
success rates of transposition of the great vessels and endo-
vascular repair were 97% and 92%, respectively. In our study, 
supra-aortic transposition was successful in all patients and 
the technical success rate of endovascular repair was 85.7%. 
No deaths related to supra-aortic transposition occurred in 
our study, thereby emphasizing the safety of these procedures. 
In 2006, Saleh and Inglese
21) successfully treated 15 aortic an-
eurysms using combined transposition of the supra-aortic gr-
eat vessels and endovascular stent graft deployment. The suc-
cess rate of these procedures was 100%. All stent grafts and by-
pass vessels were patent without endoleaks, stent displacement, 
or neurological deficits in the early postoperative period. One 
patient died 2 months postoperatively because of a pulmonary 
complication. In our study, except for one case in which endo-
leak was noted immediately after the procedure, all stent gr-
afts and bypass vessels were patent without stent displacement 
in the early postoperative period. Each case in which endovas-
cular stent grafting was performed after supra-aortic transpo-
sition of the great vessels was successful not only in effectively 
sealing or excluding the aortic arch lesions, but also in preserv-
ing the blood supply to the brain. There were no peri- or post-
operative neurological complications, indicating that a combi-
nation of open supra-aortic transposition of the great vessels fol-
lowed by endovascular stent grafting is an effective and safe me-
thod for treating aortic arch pathology.
Persistent primary endoleak was noted in one patient. Type 
I endoleak occurring after stent graft implantation can usu-
ally be treated by performing balloon angioplasty of the stent 
graft to make the stent tightly adhere to the blood vessel 
wall.
22) This patient had diffuse extensive aortic aneurysm from 
the ascending aorta to the suprarenal abdominal aorta. After 
supra-aortic transposition (LSCA to LCCA anastomosis), a 
stent graft (Seal Thoracic 38×125 mm) was deployed. The 
problem, however, was that the proximal landing zone in-
cluded aneurismal change with a diameter of around 36 mm. 
The stent graft was therefore not able to adhere to the aortic 
wall completely by balloon angioplasty. Immediate postop-
erative and follow-up CT scans showed persistent endoleak 
at the proximal site of the stent graft. To achieve sufficient 
proximal landing zone at the ascending aorta, Y-shaped by-
pass surgery with a prosthetic graft to connect the aorta to 
the supra-aortic vessels might have been helpful in this pa-
tient. Follow-up CT scan revealed no change in aortic diam-
eter despite persistent endoleak, so secondary intervention 
was not indicated. 
In one patient who underwent stent graft placement th-
rough a percutaneous approach, bleeding was not controlled 
at the access site after removal of the sheath. Emergent oper-
ation revealed the puncture site to be located around the bi-
furcation site of the superficial and deep femoral arteries, sh-
owing that the suture-mediated closure device had not worked 
properly. In this technique, care should be taken to puncture 
the CFA along its anterior aspect at least 1 cm proximal to the 
origin of the deep femoral artery. This can be confirmed by 
femoral angiography using an ipsilateral oblique projection. 
In summary, the use of combined open and endovascular 
repair in the treatment of aortic arch pathology appears safe 
and effective at perioperative, postoperative and early midterm 
follow-up and offers several advantages over conventional 
repair, including the potential to offer therapy to patients who 
are not candidates for open repair and a shorter time between 
stages for patients requiring two-stage repair. 
Conclusions
Our experience suggests that combined open and endovas-
cular repair for aortic arch pathology is safe and effective, with 
few complications. In cases without sufficient landing zone 
for stent graft at the proximal end, complete or partial supra-
aortic transposition of the great vessels can be performed to 
ensure both cerebral blood supply and sufficient landing 
zone for the stent graft. Given the small population and rela-
tively short follow-up period of our study, a much larger clini-
cal study with a longer follow-up period may be warranted to 
further demonstrate the efficacy of this procedure. 
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